<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Pharmacophore</journal-id>
      <journal-id journal-id-type="publisher-id">pharmacophorejournal.com</journal-id>
      <journal-id journal-id-type="publisher-id">Pharmacophore</journal-id>
      <journal-title-group>
        <journal-title>Pharmacophore</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2229-5402</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">pharmacophorejournal.com-6822</article-id>
      <article-id pub-id-type="doi">10.51847/TBlH98sXcQ</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Obstruction and Approaches to Cross the Drug Molecules through Blood Retinal Barrier: An Overview</article-title>
      </title-group>
                    <contrib-group>
                      <contrib contrib-type="author">
              <name>
                <surname>Seethamraju</surname>
                <given-names>Sarvan Manikiran</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Nori</surname>
                <given-names>Lakshmi Prasanthi</given-names>
              </name>
                              <xref rid="aff2" ref-type="aff">2</xref>
                                                            <xref rid="cor1" ref-type="corresp" />
                          </contrib>
                  </contrib-group>
                  <aff id="aff1">
            <label>1</label>Department of Pharmacognosy, Vignan Pharmacy College, Vadlamudi, India.
          </aff>
                  <aff id="aff2">
            <label>2</label>Department of Pharmaceutical Sciences, Sri Vishnu College of Pharmacy, Bhimavaram, India.
          </aff>
                          <author-notes>
            <corresp id="cor1">
              <bold>Address for correspondence:</bold> Prof. Wael Abu Dayyih, Department of
              Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
                              E-mail: <email xlink:href="prasanthi_pharm@yahoo.com">prasanthi_pharm@yahoo.com</email>
                          </corresp>
          </author-notes>
                    <pub-date pub-type="epub">
        <day>28</day>
        <month>08</month>
        <year>2024</year>
      </pub-date>
      <volume>15</volume>
      <issue>4</issue>
      <fpage>20</fpage>
      <lpage>32</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Pharmacophore
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>It is a challenging task to administer the appropriate quantities of drugs to the eye mainly to the retina. Retinal transmission is urgently required due to potential vision loss caused by retinal disease. The failure to provide retinal transmission of topical or systemic routes is now widely accepted. The intravitreal path offers a high regional density of drugs which induces cataracts, retinal detachment, and endophthalmitis. Periocular route utilizing the sclera&amp;#39;s permeability for the transmission of retinal dug. Systemically administered drugs must clear the retinal blood barrier (BRB) to show the action. The internal and outward flow of drugs is carefully regulated by highly specialized ocular barriers. A better understanding of these biological barriers could lead to new developments in ophthalmic drug therapy, including customised administration and minimally harmful side effects. This study primarily investigated the anatomical structure of the eye, specifically the blood-retinal barrier (BRB), different methods of drug administration, the importance of BRB physiology, such as its barrier functions, and the impact of influx and efflux transporters on delivering medications to the retina.</p>
      </abstract>
      <kwd-group>
                <kwd>Retina</kwd>
                <kwd>Periocular</kwd>
                <kwd>Barriers</kwd>
                <kwd>Transporters</kwd>
                <kwd>Influx/efflux</kwd>
              </kwd-group>
    </article-meta>
  </front>
</article>